Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Pilot Trial of Robotic Hand Therapy After Stroke

9 de julio de 2026 actualizado por: Johanne Higgins, Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal

Robotic-Assisted Hand Therapy for Neurorehabilitation in Adults With Hand Sensorimotor Impairments Following a Stroke: A Pilot Randomized Controlled Trial

This pilot study will test whether the GRIP program-a soft robotic glove with virtual-reality training-can improve hand and arm function in adults undergoing inpatient rehabilitation after a recent stroke. About 20 participants will be randomly assigned to either the GRIP program or action-observation therapy with education, in addition to usual care. The study will assess motor improvement, safety, and acceptability over approximately six weeks.

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Intervención / Tratamiento

Descripción detallada

The goal of this pilot clinical trial is to determine whether the Glove for Rehabilitation and Interactive Practice (GRIP) program can help improve hand and arm movement in adults who have difficulty using their hand after a recent stroke. The GRIP program uses a soft robotic glove and a virtual reality training platform. It is added to the usual rehabilitation care that participants already receive.

The main questions this study aims to answer are:

  • Does the GRIP program help improve hand and arm movement?
  • Is the GRIP program safe?
  • Do participants find the GRIP program acceptable, comfortable, and engaging? (qualitatively).

Researchers will compare the Glove for Rehabilitation and Interactive Practice (GRIP) program with action-observation therapy and education. Action-observation therapy means watching videos of hand movements and then practicing the same movements. Both groups will also receive their usual rehabilitation care. This study will include about 20 adults who are in an inpatient rehabilitation program after a stroke and who have difficulty using their hand.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

20

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Copia de seguridad de contactos de estudio

Ubicaciones de estudio

  • Canadá
    • Quebec
      • Montreal, Quebec, Canadá, H3S 2J4
        • Institut de réadaptation Gingras-Lindsay-de-Montréal
        • Contacto:
        • Contacto:
        • Sub-Investigador:
          • Katherine Samuel, Master's degree
        • Investigador principal:
          • Marika Demers, PhD
        • Investigador principal:
          • Johanne Higgins, PhD

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

  • Adulto
  • Adulto Mayor

Acepta Voluntarios Saludables

No

Descripción

Inclusion Criteria:

  • First unilateral stroke (<6-month post-stroke at enrollment)
  • ≥18 years old
  • Hand sensorimotor impairments
  • Able to understand and follow a two-step instruction
  • Admitted to the rehabilitation center and participating in the stroke program

Exclusion Criteria:

  • Severe spasticity (score ≥3 on the Modified Ashworth Scale)
  • Unilateral spatial neglect
  • Moderate to severe hand pain
  • Significant motor impairment of the fingers (active finger flexion/extension less than 10°)
  • Any medical condition that may interfere with participation

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Glove for Rehabilitation and Interactive Practice (GRIP) program
10 participants will be randomly assigned to this group.
Dispositivo: robotic-assisted hand therapy
Participants will receive the GRIP program in addition to usual rehabilitation care. The program uses a soft robotic glove worn on the affected hand together with a non-immersive virtual-reality system that displays hand exercises and a virtual hand that moves with the participant's real movements. The glove can provide assistance or resistance to support grasping practice and strengthening. Training focuses on repeated grasping tasks and strategies to increase use of the affected hand in daily activities. The program includes ten supervised 30-minute sessions over two weeks.
Otros nombres:
  • hand exosqueleton coupled with a virtual reality program
Comparador activo: Action-Observation Therapy (AOT) and Education
10 participants will be randomly assigned to this group.
Conductual: Action-observation therapy & Education
Participants will receive usual rehabilitation care plus action-observation therapy (AOT). They will complete ten self-directed 30-minute AOT sessions over two weeks. Each session consists of repeated cycles of watching short videos of hand movements and then attempting to reproduce those movements with the affected hand. Videos will match the grasp types practiced in the intervention arm. Participants will also attend three individual education sessions on post-stroke arm and hand recovery, including strategies to increase use of the affected hand in daily activities.
Otros nombres:
  • Educación
  • Action-Observation Therapy

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Fugl-Meyer Assessment Upper Extremity (FMA-UE)
Periodo de tiempo: At enrollment , post-intervention (at 2 weeks), and 1 month follow-up (at 6 weeks)
It is a stroke-specific, performance-based impairment index designed to measure upper extremity motor recovery after stroke.
At enrollment , post-intervention (at 2 weeks), and 1 month follow-up (at 6 weeks)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Action Research Arm Test
Periodo de tiempo: At enrollment, post-intervention (at 2 weeks), 1 month follow-up (at 6 weeks)
Observational measure that examines upper limb functional recovery
At enrollment, post-intervention (at 2 weeks), 1 month follow-up (at 6 weeks)

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Box and Blocks
Periodo de tiempo: At enrollment, post-intervention (at 2 weeks), 1 month follow-up (at 6 weeks)
Unilateral gross manual dexterity
At enrollment, post-intervention (at 2 weeks), 1 month follow-up (at 6 weeks)
Nine-Hole Peg Test
Periodo de tiempo: At enrollment, post-intervention (at 2 weeks), 1 month follow-up (at 6 weeks)
Fine manual dexterity
At enrollment, post-intervention (at 2 weeks), 1 month follow-up (at 6 weeks)
ABILHAND questionnaire
Periodo de tiempo: At enrollment, post-intervention (at 2 weeks), 1 month follow-up (at 6 weeks)
Semi-structured item-response questionnaire that measures manual ability according to an individual's perceived difficulty performing daily bimanual tasks.
At enrollment, post-intervention (at 2 weeks), 1 month follow-up (at 6 weeks)
Hand dynamometer
Periodo de tiempo: At enrollment, post-intervention (at 2 weeks), 1 month follow up (at 6 weeks)
Grip strength measurement
At enrollment, post-intervention (at 2 weeks), 1 month follow up (at 6 weeks)
Pinch gauge
Periodo de tiempo: At enrollment, post-intervention (at 2 weeks), 1 month follow-up (at 6 weeks)
To measure 2-finger pinch, 3-finger pinch and lateral pinch
At enrollment, post-intervention (at 2 weeks), 1 month follow-up (at 6 weeks)
Semi-structured interview with the GRIP group
Periodo de tiempo: Post-intervention (at 2 weeks).
A qualitative semi-structured interview on the satisfaction with the intervention, perceived benefits, tolerance and engagement
Post-intervention (at 2 weeks).

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal

Colaboradores

National Research Council, Canada

Investigadores

  • Director de estudio: Johanne Higgins, PhD, Université de Montréal, CRIR
  • Director de estudio: Marika Demers, PhD, Université de Montréal, CRIR

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de agosto de 2026

Finalización primaria (Estimado)

1 de julio de 2027

Finalización del estudio (Estimado)

1 de julio de 2027

Fechas de registro del estudio

Enviado por primera vez

9 de julio de 2026

Primero enviado que cumplió con los criterios de control de calidad

9 de julio de 2026

Publicado por primera vez (Actual)

16 de julio de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

16 de julio de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

9 de julio de 2026

Última verificación

1 de julio de 2026

Más información

Términos relacionados con este estudio

Palabras clave

Términos MeSH relevantes adicionales

Otros números de identificación del estudio

  • 2026-2490

Plan de datos de participantes individuales (IPD)

¿Planea compartir datos de participantes individuales (IPD)?

NO

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Suscribir